Advanced Multiple Sclerosis research hub
3 indexed studies · 2 currently recruiting
- active not recruitingPHASE2, PHASE3
ChariotMS - Cladribine to Halt Deterioration in People With Advanced Multiple Sclerosis
This study is testing a new use for a drug called Cladribine (Mavenclad) for people with advanced Multiple Sclerosis (MS). We want to see if it can slow down MS progression and improve quality of life.
United Kingdom - recruitingPHASE1
Obe-cel in Refractory Progressive Forms of Multiple Sclerosis
This study is looking into a new treatment called obe-cel for adults with a progressive form of multiple sclerosis (MS) that hasn't responded to other treatments. It aims to see if obe-cel is safe and if it shows early signs of helping with MS.
United States · Spain · United Kingdom - recruitingPHASE2
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as Add-on Therapy to Ocrelizumab, in Participants With Progressive Forms of Multiple Sclerosis (MS)
This study looks at a new medicine called RO7268489 for people with progressive multiple sclerosis (MS) who are already taking ocrelizumab. We want to see if adding RO7268489 helps, and if it's safe. Some people might also get the new medicine after the main part of the study.
Australia · France · Germany